|
The Johnson & Johnson Diabetes Institute has opened its first four facilities in Japan, China, Europe/Middle East/Africa region, and North America. Curricula are customized to the needs and providers and developed in consultation with leaders of international diabetes organizations, public health institutions, and key opinion leaders.
 |
Located in Tokyo, Japan, the first facility was launched in October 2007 and features a four-tiered university approach, with beginning, intermediate, advanced, and professional courses in diabetes care. This reflects the desire among Japanese Diabetes Educators for current and consistent training and education. Japan has almost 7.5 million diabetes patients.
|
 |
In the heart of Silicon Valley, California, this facility offers intensive classes on a range of topics, including chronic care models, optimization and intensification of insulin, use of insulin pump therapy, blood glucose management software solutions, reimbursement, innovative practice models, patient communication skills, and family dynamics. All courses include hands on product training on the use of Animas insulin pumps and OneTouch blood glucose meters and diabetes management software. The United States has almost 24 million people with diabetes. The Silicon Valley Institute launched in February 2008.
|
 |
Opened in Bejing, the China facility is designed to reflect the country’s hospital-driven healthcare system. This facility is led by Professor Pan Changyu, Chairman of the Johnson & Johnson Diabetes Institute China. The focus is on diabetes management practices. The curriculum is designed to provide certification of Diabetes Educators from the Ministry of Health for the first time in China. The country has almost 40 million diabetes patients, second only to India.
|
 |
Europe, the Middle East, and Africa’s (EMEA) first Johnson & Johnson Diabetes Institute is located in Paris and features a range of intensive courses that revolve around therapeutic patient education. The Institute has a Pan-EMEA approach to diabetes care. Experts have predicted that, by 2025, the number of people with diabetes will have increased by 20 percent within Europe, 80 percent within Eastern Mediterranean and Middle East populations, and 80 percent in African populations
Learn more by visiting the EMEA Institute Home Page.
|
|
|
|
|
|
